Sprint Bioscience AB (SPRINT) — Free Cash Flow Generation Index
Sprint Bioscience AB (SPRINT) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of Skr115.78 Million represents 1% of operating cash flow (Skr115.84 Million). See SPRINT working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sprint Bioscience AB Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Sprint Bioscience AB across 4 annual periods. Explore SPRINT debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Sprint Bioscience AB (2015–2025)
Year-by-year Free Cash Flow Generation Index for Sprint Bioscience AB. For the full company profile including market capitalisation, see how much is Sprint Bioscience AB worth.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | Skr83.44 Million | Skr83.53 Million | Skr94.00K | ▲ +11.9% |
| 2023 | 0.89x | Skr20.42 Million | Skr22.87 Million | Skr2.45 Million | ▲ +458.9% |
| 2016 | -0.25x | Skr-1.97 Million | Skr7.93 Million | Skr9.91 Million | ▲ +96.1% |
| 2015 | -6.43x | Skr-5.36 Million | Skr833.54K | Skr6.19 Million | — |